Seth Divya, Wang Sophie, Ezaldein Harib H, Merati Miesha, Scott Jeffrey F
Case Western Reserve University School of Medicine, Cleveland.
Dermatol Online J. 2019 Jan 15;25(1):13030/qt8sq5j6vk.
Acne vulgaris affects a large portion of the population and drives many patients to seek over-the-counter (OTC) treatments. Light-emitting diode (LED) therapy has recently emerged as a potential therapeutic option for inflammatory acne. We used the U.S. Food and Drug Administration (FDA) 510(k) premarket submission database to assess the growth in OTC LED therapy devices for treatment of acne. We also used Google Trends data in searches for "acne light therapy mask" to characterize growth in consumer interest in these devices. Overall, 35 LED devices received pre-market approval from 2000 to 2018, with a peak in approvals in 2016. Similarly, there was a dramatic increase in public interest in these devices in 2016. Only two devices were associated with company-approved trials. The current regulatory process requires little evidence to substantiate specified uses and a better understanding of practice guidelines and the efficacy of this treatment modality is required.
寻常痤疮影响着很大一部分人群,促使许多患者寻求非处方(OTC)治疗方法。发光二极管(LED)疗法最近已成为炎性痤疮的一种潜在治疗选择。我们利用美国食品药品监督管理局(FDA)的510(k)上市前提交数据库来评估用于治疗痤疮的非处方LED治疗设备的增长情况。我们还使用了谷歌趋势中“痤疮光疗面罩”的搜索数据来描述消费者对这些设备兴趣的增长情况。总体而言,2000年至2018年期间有35种LED设备获得了上市前批准,2016年批准数量达到峰值。同样,2016年公众对这些设备的兴趣也急剧增加。只有两款设备与公司批准的试验相关。目前的监管程序几乎不需要证据来证实特定用途,因此需要更好地了解实践指南以及这种治疗方式的疗效。